Position in TLRY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$149,912
-$91,651 QoQ
Shares Held
33,388
-10.6% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 235 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Derivatives in TLRY
reported options exposure · as of Sep 30, 2025CallValue
$17,300
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $154,257,402 across 47 Drug Manufacturers - Specialty & Generic names. TLRY ranks #37 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
368,249 | $26,462,373 | |
| 2 | HLN |
Haleon plc
|
2,036,156 | $18,997,335 | |
| 3 | PRGO |
PERRIGO Co plc
|
1,431,267 | $14,870,864 | |
| 4 | VTRS |
Viatris Inc
|
678,057 | $10,767,545 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
432,525 | $10,644,440 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
62,420 | $10,520,266 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
258,667 | $8,967,984 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
555,228 | $8,900,304 |
All Filings in TLRY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $149,912 | 33,388 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $241,563 | 37,336 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $423,001 | 46,844 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $574,349 | 331,994 | Shares | Sole | 2025-11-12 | |
| 2025-09-30 | $17,300 | 10,000 | Call | Sole | 2025-11-12 | |
| 2025-06-30 | $117,680 | 287,026 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $140,919 | 213,514 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $277,694 | 208,793 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $533,485 | 303,117 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $654,898 | 394,517 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $856,092 | 346,596 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $774,920 | 336,922 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $514,466 | 215,258 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $396,208 | 253,980 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $801,043 | 316,618 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $774,391 | 287,878 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $703,279 | 255,738 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $802,698 | 257,275 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,540,424 | 326,953 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,265,442 | 180,006 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,851,255 | 252,547 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,655,830 | 202,203 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,114,071 | 93,008 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $579,447 | 70,151 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $248,087 | 51,152 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $174,123 | 24,490 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $162,932 | 23,682 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||